[How to manage EBV reactivation and EBV-PTLD, CMV and human herpesvirus 6 reactivation and infection after allogeneic stem cell transplantation: A report of the SFGM-TC (update)].

Authors :: Brissot E
Alsuliman T
Gruson B
Hermet E
Tirefort Y
Yakoub-Agha I
Alain S
Source :: Bulletin du cancer [Bull Cancer] 2017 Dec; Vol. 104 (12S), pp. S181-S187. Date of Electronic Publication: 2017 Nov 21.
Publication Year :: 2017
Abstract: The French society of bone marrow transplantation and cell therapy (SFGM-TC) organizes annually workshops in the attempt to harmonize clinical practices between different francophone transplantation center. Here, we report our recommendations regarding the management of Epstein Barr virus reactivation and lymphoproliferative disorders, cytomegalovirus (CMV) and human herpes virus 6 (HHV6) after allogeneic stem cell transplantation.<br /> (Copyright © 2017 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.)

Full Text Access

Tools